FDA chief confirms mifepristone review but ‘no plans’ to change access

From MSNBC.

On #MorningJoe, FDA Commissioner Dr. Marty Makary weighed in on the ongoing review of mifepristone at Secy. RFK Jr’s direction. When pressed by Ali Vitali, Makary confirmed his stance remains that he won’t take action on changing access to the drug.

For more context and news coverage of the most important stories of our day click here: https://www.msnbc.com/

» Subscribe to MSNBC: https://www.youtube.com/msnbc
» Subscribe to MSNBC on TikTok https://www.tiktok.com/@msnbc
» Subscribe to MSNBC on Instagram https://www.instagram.com/msnbc
Download our new MSNBC app for the latest breaking news and daily headlines at a glance: https://www.msnbc.com/information/download-msnbc-app-n1241692

Follow MSNBC Show Blogs
MaddowBlog: https://www.msnbc.com/maddowblog

MSNBC delivers breaking news, in-depth analysis of political headlines, commentary and informed perspectives. Find video clips and segments from The Rachel Maddow Show, Inside with Jen Psaki, Morning Joe, The Beat, Deadline: White House, All In, The Last Word, The 11th Hour, and more.

Connect with MSNBC Online
Visit msnbc.com: https://www.msnbc.com/
Subscribe to the MSNBC Daily Newsletter: https://link.msnbc.com/join/5ck/msnbc-daily-signup